ARCHIVES

New Health Bills Could Affect Cancer Program

This article is from The Cancer Letter archive.

Vol. 05 No. 06 | February 9, 1979

Download PDF Visit The Full Archive

Related Articles

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

September 7, 1990

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999